Wednesday May 15
Illumina Rating Reiterated by Bank of America
's stock had its "positive" rating reaffirmed by research analysts at Bank of America in a report released on Wednesday, Analyst Ratings Network.com reports.
Sat May 11, 2013
Secrets to Making Money in LNKD, MCD, ILMN and FCX
Don't waste time trying to figure it out for yourself; tip the scales in your favor and add our experience to your team.
Tue May 07, 2013
Personalis Announces Illumina CSPro Certification for Sequencing
Personalis announced today that it has successfully completed Illumina CSPro certification for sequencing on HiSeq and MiSeq, gaining entry to an elite group of Illumina genomics service providers globally.
Tue Apr 30, 2013
3 Biotechs Flying Under The Radar
As biotechnology investors, we often spend countless hours considering the next cure for cancer and many other advancements most often made by pharmaceutical companies.
Thu Apr 25, 2013
Verinata Health Publishes Clinical Laboratory Performance Data for verifiA Prenatal Test
Illumina, Inc. today announced that Verinata Health, an Illumina company, has published the first peer-reviewed study of non-invasive prenatal test performance in a clinical laboratory setting.
Illumina's Solid Quarter Highlights Macroeconomic Resilience, Market Opportunity
On April 22, after the close of trading, Illumina released its Q1 2013 earnings, delivering another solid quarter in the face of perceived uncertainty.
Wed Apr 24, 2013
Illumina Price Target Increased to $55.00 by Analysts at Wedbush
The firm currently has a "neutral" rating on the stock. A number of other firms have also recently commented on ILMN.
Tue Apr 23, 2013
NASDAQ Gain Investor Support
Netflix, Inc. has released its earnings report for the first three months of the year, pushing the price per stock up.
4 lessons from a failed IBM-Roche collaboration
There's been plenty of great press -- you might even say hype -- about IBM's "DNA transistor," a new type of gene sequencing technology that had come out of the company's labs.
Illumina Jumps Most in 15 Months as First-Quarter Profit Beats Estimates
Illumina Inc. rose the most in almost 15 months after the maker of genetic decoders reported earnings that exceeded analysts' estimates on higher sales.
Investor's Business Daily
Earnings Reports Boost Stocks; Netflix, Veeco, Illumina Spike
Dow futures were up 64 points and rising. Nasdaq 100 futures were ahead a strong 18.25 points, while S&P 500 futures rose 6.75 points.
Prenatal DNA Sequencing
Earlier this year Illumina, the maker of the world's most widely used DNA sequencing machines, agreed to pay nearly half a billion dollars for Verinata, a startup in Redwood City, California, that has hardly any revenues.
Mon Apr 22, 2013
Illumina Management Discusses Q1 2013 Results - Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the First Quarter 2013 Illumina Earnings Conference Call.
Illumina Names Charles Dadswell as Senior Vice President and General Counsel
Illumina, Inc. today announced it has appointed Charles Dadswell as Senior Vice President and General Counsel.
Illumina (ILMN) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Illumina released its earnings data on Monday. The company reported $0.46 earnings per share for the quarter, beating the analysts' consensus estimate of $0.39 by $0.07, StocKRatingsNetwork.com reports.
Illumina Reports Strong Start to Fiscal Year 2013
GAAP net loss for the quarter of $23 million, or $0.18 per diluted share due to a charge of $106.9 million related to the Syntrix Biosystems, Inc.